$GLUE
Monte Rosa Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$12.25
▼-2.78%-$0.350
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateMonte Rosa Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is GLUE down today? It is at $12.25 (-2.78%), and our scanner flagged it 47 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment GLUE spikes, and full due diligence on GLUE — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $GLUE 47 times in the last 30 days. Create a free account to track $GLUE, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on GLUE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GLUE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Warmuth Markus Officer | Sold (automatic/other) | -10K 0.01% of company | sold 1.6% | 585K | $220K at $23.18 | Jul 16, 26 |
Champoux Jennifer Officer | Sold (automatic/other) | -4K | sold 6.5% | 62K | $102K at $23.38 | Jul 15, 26 |
Champoux Jennifer Officer | Other | 4K | added 7.0% | 67K | $17K at $3.98 | Jul 15, 26 |
Townson Sharon Officer | Sold (automatic/other) | -6K | sold 8.1% | 68K | $140K at $23.25 | Jul 6, 26 |
Townson Sharon Officer | Other | 6K | added 8.8% | 74K | $37K at $6.14 | Jul 6, 26 |
Behbahani Ali Director | Acquired (grant/award) | +15K 0.02% of company | n/a | 15K | n/a | Jul 1, 26 |
Behbahani Ali Director | Sold (automatic/other) | -1.01M 1.2% of company | sold 13% | 6.69M | n/a | Jul 1, 26 |
Janku Filip Officer | Sold (automatic/other) | -5K | sold 8.2% | 61K | $132K at $24.50 | Jun 30, 26 |
Janku Filip Officer | Other | 5K | added 8.9% | 66K | $73K at $13.41 | Jun 30, 26 |
Manning Anthony M. Director | Sold (automatic/other) | -10K 0.01% of company | n/a | n/a | $231K at $23.11 | Jun 29, 26 |
Manning Anthony M. Director | Other | 10K 0.01% of company | n/a | 10K | $42K at $4.16 | Jun 29, 26 |
Janku Filip Officer | Sold (automatic/other) | -6K | sold 9.1% | 60K | $138K at $22.95 | Jun 29, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on GLUE from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for GLUE today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
GLUE last traded at $12.25, down 2.78% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Monte Rosa Therapeutics, Inc. Common Stock (GLUE) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The GLUE Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged GLUE 47 times in the last 30 days.
GLUE (Monte Rosa Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $1.03B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge GLUE for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$GLUE discussion
Sign in to ask a question or join the discussion.